| 1 | 1369764-02-2 | 莱博雷生 | Lemborexant | C22H20F2N4O2
| 抑制剂;原料药及中间体 | |
| 2 | 544678-85-5 | N4,N6-双(4-氟-3-甲基苄基)嘧啶-4,6-二甲酰胺 | MMP-13 Inhibitor | C22H20F2N4O2
| | |
| 3 | | N4,N6-双(4-氟-3-苄基)嘧啶-4,6-二甲酰胺 | N4,N6-BIS(4-FLUORO-3-METHYLBENZYL)PYRIMIDINE-4,6-DICARBOXAMIDE | C22H20F2N4O2
| | |
| 4 | | N4,N6-Bis(4-fluoro-3-methylbenzyl)pyrimidine-4,6-dicarboxamide ,97% | N4,N6-Bis(4-fluoro-3-methylbenzyl)pyrimidine-4,6-dicarboxamide ,97% | C22H20F2N4O2
| | |
| 5 | 2306442-63-5 | 4-[(4-cyano-2,6-difluorophenyl)methylene]-N-(3,4-dihydro-2H-pyrano[3,2-b]pyridin-8-yl)piperidine-1-carboxamide | 4-[(4-cyano-2,6-difluorophenyl)methylene]-N-(3,4-dihydro-2H-pyrano[3,2-b]pyridin-8-yl)piperidine-1-carboxamide | C22H20F2N4O2
| | |